Sökning: onr:"swepub:oai:DiVA.org:umu-168871" >
Clinical course and...
Clinical course and need for hospital admission after lithium discontinuation in patients with bipolar disorder type I or II : mirror-image study based on the LiSIE retrospective cohort
-
- Öhlund, Louise (författare)
- Umeå universitet,Psykiatri
-
- Ott, Michael (författare)
- Umeå universitet,Avdelningen för medicin
-
Bergqvist, Malin (författare)
-
visa fler...
-
Oja, Sofia (författare)
-
Lundqvist, Robert (författare)
-
- Sandlund, Mikael (författare)
- Umeå universitet,Psykiatri
-
- Renberg, Ellinor Salander (författare)
- Umeå universitet,Psykiatri
-
- Werneke, Ursula (författare)
- Umeå universitet,Psykiatri,Sunderby Research Unit
-
visa färre...
-
(creator_code:org_t)
- 2019-11-22
- 2019
- Engelska.
-
Ingår i: BJPsych Open. - : Cambridge University Press. - 2056-4724. ; 5:6
- Relaterad länk:
-
https://doi.org/10.1...
-
visa fler...
-
https://umu.diva-por... (primary) (Raw object)
-
https://www.cambridg...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- Background: Currently, the evidence for lithium as a maintenance treatment for bipolar disorder type II (BD-II) remains limited. Guidelines commonly extrapolate recommendations for BD-II from available evidence for bipolar disorder type I (BD-I). Comparing the impact of lithium discontinuation is one way of assessing effectiveness in both groups.Aims: To compare the impact of lithium discontinuation on hospital admissions and self-harm in patients with BD-I or schizoaffective disorder (SZD) and patients with BD-II or other bipolar disorder.Method: Mirror-image study, examining hospital admissions within 2 years before and after lithium discontinuation in both patient groups. This study was part of a retrospective cohort study (LiSIE) into effects and side-effects of lithium for maintenance treatment of bipolar disorder as compared with other mood stabilisers.Results: For the whole sample, the mean number of admissions/patient/review period doubled from 0.44 to 0.95 (P<0.001) after lithium discontinuation. The mean number of bed days/patient/review period doubled from 11 to 22 (P = 0.025). This increase in admissions and bed days was exclusively attributable to patients with BD-I/SZD. Not having consulted with a doctor prior to lithium discontinuation or no treatment with an alternative mood stabiliser at the time of lithium discontinuation led to more admissions.Conclusions: The higher relapse risk in patients with BD-I/SZD suggests a higher threshold for discontinuing lithium than for patients with BD-II/other bipolar disorder. In patients with BD-II/other bipolar disorder, however, judged on the impact of discontinuation alone, lithium did not appear to prevent more severe depressive episodes requiring hospital admission.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Psykiatri (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Psychiatry (hsv//eng)
Nyckelord
- Bipolar disorder
- lithium
- mood stabiliser
- admission
- hospitalisation
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas